Shayne & Jacobs LLC’s AstraZeneca AZN Stock Holding History

Shayne & Jacobs LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,000	Closed	-$324K	–	22
2014 Q1	$324K	Hold	5,000	–	–	0.26%	15
2013 Q4	$297K	Hold	5,000	–	–	0.25%	15
2013 Q3	$260K	Hold	5,000	–	–	0.23%	15
2013 Q2	$237K	Buy	+5,000	New	+$255K	0.21%	17

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Shayne & Jacobs LLC's AZN Position: Q2 2014 in Review

Shayne & Jacobs LLC sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 5,000 shares — an estimated $324K sold.

Shayne & Jacobs LLC first reported a position in AZN in Q2 2013 and held it in 4 quarters. The position peaked at $324K in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Shayne & Jacobs LLC reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
Shayne & Jacobs LLC sold 5,000 AstraZeneca shares in Q2 2014, an estimated $324K.
Shayne & Jacobs LLC first reported a position in AstraZeneca in Q2 2013 and held it in 4 quarters.
Shayne & Jacobs LLC's AstraZeneca position peaked at $324K in Q1 2014.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Shayne & Jacobs LLC's 13F filing for Q2 2014, filed 28 Jul 2014.